41,062 Shares in Privia Health Group, Inc. $PRVA Acquired by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 41,062 shares of the company’s stock, valued at approximately $922,000.

A number of other large investors have also recently added to or reduced their stakes in PRVA. LPL Financial LLC bought a new stake in Privia Health Group during the fourth quarter worth approximately $199,000. Wells Fargo & Company MN boosted its holdings in Privia Health Group by 50.6% during the fourth quarter. Wells Fargo & Company MN now owns 48,670 shares of the company’s stock worth $951,000 after buying an additional 16,357 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Privia Health Group by 10.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company’s stock worth $27,687,000 after buying an additional 138,747 shares in the last quarter. MetLife Investment Management LLC raised its holdings in Privia Health Group by 5.8% during the 4th quarter. MetLife Investment Management LLC now owns 62,336 shares of the company’s stock worth $1,219,000 after buying an additional 3,406 shares during the period. Finally, State of Tennessee Department of Treasury raised its holdings in Privia Health Group by 18.1% during the 4th quarter. State of Tennessee Department of Treasury now owns 57,075 shares of the company’s stock worth $1,116,000 after buying an additional 8,733 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

PRVA has been the topic of several recent analyst reports. Piper Sandler cut their price objective on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Barclays boosted their price objective on Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 27th. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Evercore ISI cut their price objective on Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, July 9th. Finally, JPMorgan Chase & Co. boosted their price objective on Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a report on Wednesday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $28.00.

Privia Health Group Price Performance

Shares of PRVA opened at $21.75 on Thursday. The company has a market capitalization of $2.67 billion, a price-to-earnings ratio of 197.75, a P/E/G ratio of 3.10 and a beta of 0.80. Privia Health Group, Inc. has a fifty-two week low of $16.47 and a fifty-two week high of $26.09. The business’s 50-day moving average is $20.89 and its 200-day moving average is $22.68.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The business had revenue of $521.15 million during the quarter, compared to analyst estimates of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. Privia Health Group’s revenue for the quarter was up 23.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. Equities research analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.